Ovarian Cancer

The CA 125 Test measures the level of cancer antigen 125 in blood, a protein often elevated in ovarian cancer and some other conditions. While not used alone for diagnosis, it helps monitor treatment effectiveness, detect recurrence, or assess disease progression. Elevated CA 125 may also be seen in endometriosis, fibroids, or pelvic inflammation. Doctors use this test to support cancer management and track overall reproductive and abdominal health.

The CA 125 Test with HAMA Treatment measures levels of cancer antigen 125, a biomarker often elevated in ovarian cancer and some benign conditions. The addition of human anti-mouse antibody (HAMA) treatment minimizes assay interference, improving result accuracy. This test supports evaluation of suspected ovarian malignancy, monitoring of treatment response, and detection of disease recurrence.

The CEA Test measures carcinoembryonic antigen levels in blood, a protein that may be elevated in certain cancers, especially colorectal, pancreatic, lung, breast, or ovarian cancer. It is not used alone for diagnosis but helps monitor cancer treatment, detect recurrence, and track disease progression. Elevated CEA can also occur in noncancerous conditions. Doctors use this test to support therapy decisions and provide insight into cancer management.

The Inhibin A Test measures levels of inhibin A, a hormone produced by the ovaries and placenta. Abnormal levels may indicate ovarian function disorders, fertility issues, or serve as a marker in prenatal screening for chromosomal abnormalities such as Down syndrome. This test provides insight into reproductive health, hormone regulation, and pregnancy monitoring, supporting evaluation of ovarian and placental activity.

The Inhibin B Test evaluates inhibin B concentration in blood to help assess reproductive health in both men and women. In women, it is used as an indicator of ovarian reserve, follicular function, and fertility potential, while in men, it reflects Sertoli cell activity, spermatogenesis, and testicular health. This test aids in understanding hormonal balance, fertility disorders, and reproductive system function.

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

The hCG Qualitative Urine Test detects human chorionic gonadotropin in urine to confirm pregnancy. It provides a simple positive or negative result, making it similar to an at-home pregnancy test but performed in a clinical setting for greater accuracy. Doctors order this test to evaluate missed periods, early pregnancy symptoms, or before medical procedures.

The hCG Total Qualitative Test detects the presence of human chorionic gonadotropin in blood to confirm pregnancy. Unlike the quantitative test, it provides a simple positive or negative result rather than exact levels. Doctors use this test to confirm suspected pregnancy, evaluate early symptoms, or screen before medical procedures.

The hCG Total Quantitative Test measures human chorionic gonadotropin levels in blood to confirm pregnancy and monitor its progression. It provides exact hCG values, helping detect ectopic pregnancy, miscarriage risk, and abnormal growths like trophoblastic disease. Doctors also use it to track fertility treatments and evaluate certain cancers. This test offers precise insight into pregnancy health, reproductive function, and overall hormone balance.

The Lactate Dehydrogenase (LDH) Test measures LDH enzyme levels in blood to assess tissue damage and overall health. Elevated LDH may indicate conditions such as liver disease, heart attack, anemia, infections, or certain cancers, while low levels are uncommon. Doctors use this test to help diagnose disease, monitor treatment effectiveness, and track cell damage. It provides valuable insight into metabolic activity and organ function.

The CA 15-3 Test measures cancer antigen 15-3 levels in blood, often used to monitor breast cancer treatment and progression. Elevated levels may suggest advanced breast cancer, metastasis, or recurrence, while non-cancer conditions can also affect results. Doctors order this test alongside imaging and other labs to track therapy response or detect changes in disease status. Results help guide ongoing management of breast cancer and patient care.

The Estradiol (E2) Test measures levels of estradiol, the primary form of estrogen, to evaluate reproductive and hormonal health. It helps assess menstrual irregularities, fertility issues, menopause status, and estrogen-producing disorders. In men, it aids in diagnosing hormonal imbalances. Doctors use the estradiol test to monitor hormone therapy, ovarian function, and conditions affecting puberty, bone health, and overall endocrine balance.

The Estradiol and Estrone Test measures two primary forms of estrogen to assess hormonal balance, ovarian function, and endocrine health. Estradiol, the most active estrogen, and estrone, the predominant form after menopause, provide insight into reproductive health, fertility, and menopausal transition. This test aids in evaluating estrogen-related disorders, hormone therapy monitoring, and overall endocrine function.

The Estriol (E3) Test checks blood levels of estriol, an estrogen hormone important in pregnancy. It is commonly included in the second-trimester triple or quad screen to detect chromosomal disorders such as Down syndrome and assess placental function. Estriol testing helps monitor fetal growth and maternal hormone health. Low or abnormal levels may signal pregnancy complications, guiding further testing and prenatal care decisions.

The Estrogen Total Test measures all forms of estrogen in blood, including estradiol, estrone, and estriol, to assess reproductive and hormonal health. Abnormal levels may indicate menstrual irregularities, menopause status, infertility, or hormone-related disorders. Doctors order this test to evaluate fertility, monitor hormone therapy, and investigate symptoms such as hot flashes, irregular cycles, or abnormal bleeding. It provides key insight into endocrine and reproductive function.

The Estrone (E1) Test measures estrone, one of the three main estrogen hormones, to assess reproductive and hormonal health. It helps evaluate ovarian function, menstrual irregularities, menopause status, and estrogen-related disorders. In men, estrone testing may detect hormonal imbalances or excess estrogen. Doctors use this test to monitor hormone therapy, fertility treatments, and conditions affecting bone health, metabolism, and overall endocrine balance.

The Testosterone Free and Total Test measures total testosterone and free, bioavailable testosterone in blood for both men and women. It helps diagnose hormone imbalance, infertility, low libido, erectile dysfunction in men, irregular periods, or PCOS in women. Doctors also order it to assess fatigue, mood changes, or muscle weakness and to monitor hormone therapy. This test provides key insight into reproductive, endocrine, and overall metabolic health.

The Testosterone Total Test measures total testosterone levels in blood to evaluate reproductive, sexual, and endocrine health. In men, it helps diagnose hypogonadism, infertility, erectile dysfunction, or low libido. In women, abnormal levels may indicate PCOS or hormonal imbalance. Doctors use this test to investigate fatigue, muscle weakness, or mood changes and to monitor testosterone therapy. It provides key insight into hormone balance and metabolic health.